Decrease in alpha-1 antiproteinase antitrypsin is observed in primary Sjogren’s syndrome condition

References

• Fox PC. Autoimmune diseases and Sjogren’s syndrome: an autoimmune exocrinopathy. Ann N Y Acad Sci. 2007;1098:5–21.
   Web of Science ®Google Scholar
• Meijer JM, Meiners PM, Huddleston Slater JJ, et al. Health-related quality of life, employment, and disability in patients with Sjogren’s syndrome. Rheumatology. 2009;48(9):1077–1082.
   PubMed Web of Science ®Google Scholar
• Mariette X, Criswell LA. Primary Sjögren's syndrome. N Engl J Med. 2018;378(10):931–939.
   PubMed Web of Science ®Google Scholar
• Dawes C, Pedersen AM, Villa A, et al. The functions of human saliva: a review sponsored by the World Workshop on Oral Medicine VI Arch. Arch Oral Biol. 2015;60(6):863–874.
   PubMed Web of Science ®Google Scholar
• Rischmueller M, Tieu J, Lester S. Primary Sjögren's syndrome. Best Pract Res Clin Rheumatol. 2016;30(1):189–220.
   PubMed Web of Science ®Google Scholar
• Cartee DL, Maker S, Dalonges D, et al. Sjögren’s syndrome: oral manifestations and treatment, a dental perspective. J Dent Hyg. 2015;89:365–371.
   PubMedGoogle Scholar
• Baum BJ, Alevizos I, Chiorini JA, Cotrim AP, et al. Advances in salivary gland gene therapy - oral and systemic implications. Expert Opin Biol Ther. 2015;15(10):1443–1454.
   PubMed Web of Science ®Google Scholar
• Leehan KM, Pezant NP, Rasmussen A, et al. Fatty infiltration of the minor salivary glands is a selective feature of aging but not Sjögren's syndrome. Autoimmunity. 2017;50(8):451–457.
   PubMed Web of Science ®Google Scholar
• Rodrigues RA, Soares R. Inflammation in Sjögren's syndrome: cause or consequence? Autoimmunity. 2017;50(3):141–150.
   PubMed Web of Science ®Google Scholar
• Kassan SS, Moutsopoulos HM. Clinical manifestations and early diagnosis of Sjogren syndrome. Arch Intern Med. 2004;164(12):1275–1284.
   PubMedGoogle Scholar
• Mavragani CP, Moutsopoulos HM. Sjögren’s syndrome. Annu Rev Pathol. 2014;9:273–285.
   PubMed Web of Science ®Google Scholar
• Tzioufas AG, Voulgarelis M. Update on Sjögren’s syndrome autoimmune epithelitis: from classification to increased neoplasias. Best Pract Res Clin Rheumatol. 2007;21(6):989–1010.
   PubMed Web of Science ®Google Scholar
• Nakata H, Yamamoto M, Kumchantuek T, et al. Synthesis, localization and possible function of serine (or cysteine) peptidase inhibitor, clade B, member 6a (Serpinb6a) in mouse submandibular gland. Cell Tissue Res. 2017;369(3):513–526.
   PubMed Web of Science ®Google Scholar
• Sukumaran P, Sun Y, Zangbede FQ, et al. TRPC1 expression and function inhibit ER stress and cell death in salivary gland cells. FASEB Bioadv. 2019;1(1):40–50.
   PubMedGoogle Scholar
• Davies MJ, Lomas DA. The molecular aetiology of the serpinopathies. Int J Biochem Cell Biol. 2008;40(6-7):1273–1286.
   PubMed Web of Science ®Google Scholar
• Krem MM, Di Cera E. Conserved Ser residues, the shutter region, and speciation in serpin evolution. J Biol Chem. 2003;278(39):37810–37814.
   PubMed Web of Science ®Google Scholar
• Hunt JM, Tuder R. Alpha 1 anti-trypsin: one protein, many functions. Curr Mol Med. 2012;12(7):827–835.
   PubMed Web of Science ®Google Scholar
• Janciauskiene SM, Nita IM, Stevens T. Alpha1-antitrypsin exerts in vitro anti-inflammatory activity in human monocytes by elevating cAMP. J Biol Chem. 2007;282(12):8573–8582.
   PubMed Web of Science ®Google Scholar
• Gauldie J, Lamontagne L, Horsewood P, et al. Jenkins E Immunohistochemical localization of alpha 1-antitrypsin in normal mouse liver and pancreas. Am J Pathol. 1980;101(3):723–735.
   PubMed Web of Science ®Google Scholar
• Perez P, Adriaansen J, Goldsmith CM, et al. Transgenic α-1-antitrypsin secreted into the bloodstream from salivary glands is biologically active. Oral Dis. 2011;17(5):476–483.
   PubMed Web of Science ®Google Scholar
• Churg A, Dai J, Zay K, et al. Wright Alpha-1-antitrypsin and a broad spectrum metalloprotease inhibitor, RS113456, have similar acute anti-inflammatory effects. Lab Invest. 2001;81(8):1119–1131.
   PubMed Web of Science ®Google Scholar
• Nita IM, Serapinas D, Janciauskiene SM. Alpha1-antitrypsin regulates CD14 expression and soluble CD14 levels in human monocytes in vitro. Int J Biochem Cell Biol. 2007;39(6):1165–1176.
   PubMed Web of Science ®Google Scholar
• Goldstein S, Reddy P. Tolerance without toxicity? α1-antitrypsin as a novel alternative to immunosuppression. Expert Rev Clin Immunol. 2012;8(5):397–399.
   PubMed Web of Science ®Google Scholar
• Tawara I, Sun Y, Lewis EC, et al. Alpha-1-antitrypsin monotherapy reduces graft-versus-host disease after experimental allogeneic bone marrow transplantation Proc. Proc Natl Acad Sci USA. 2012;109(2):564–569.
   PubMed Web of Science ®Google Scholar
• McLean C, Greene C, McElvaney NG. Gene target therapeutics for liver disease in alpha-1 antiproteinase, antitrypsin deficiency. Biol Targets Therapy. 2009;3:63–75.
   PubMedGoogle Scholar
• Daemen MA, Heemskerk VH, van't Veer C, et al. Functional protection by acute phase proteins alpha(1)-acid glycoprotein and alpha(1)-antitrypsin against ischemia/reperfusion injury by preventing apoptosis and inflammation. Circulation. 2000;102(12):1420–1426.
   PubMed Web of Science ®Google Scholar
• Ice JA, Li H, Adrianto I, et al. Genetics of Sjögren's syndrome in the genome-wide association era. J Autoimmun. 2012;39(1-2):57–63.
   PubMed Web of Science ®Google Scholar
• Priori R, Medda EF, Conti EA, et al. Risk factors for Sjögren’s syndrome: a case-control study. Clin Exp Rheumatol. 2007;25:378–384.
   PubMed Web of Science ®Google Scholar
• Cruz-Tapias P, Rojas-Villarraga A, Maier-Moore S, et al. HLA and Sjögren’s syndrome susceptibility. A meta-analysis of worldwide studies. Autoimmun Rev. 2012;11(4):281–287.
   PubMed Web of Science ®Google Scholar
• Lessard CJ, et al. Variants at multiple loci implicated in both innate and adaptive immune responses are associated with Sjögren’s syndrome. Nat Genet. 2013;11:1284–1292.
   Google Scholar
• Dozmorov MG, Wren JD, Alarcón-Riquelme ME. Epigenomic elements enriched in the promoters of autoimmunity susceptibility genes. Epigenetics. 2014;9(2):276–285.
   PubMed Web of Science ®Google Scholar
• Brooks WH, Le Dantec C, Pers JO, et al. Epigenetics and autoimmunity. J Autoimmun. 2010;34(3):J207–219.
   PubMed Web of Science ®Google Scholar
• Renaudineau Y. The revolution of epigenetics in the field of autoimmunity. Clin Rev Allergy Immunol. 2010;39(1):1–2.
   PubMed Web of Science ®Google Scholar
• Imgenberg-Kreuz J, Sandling JK, Nordmark G. Epigenetic alterations in primary Sjögren's syndrome - an overview. Clin Immunol. 2018;196:12–20.
   PubMed Web of Science ®Google Scholar
• van Nimwegen JF, van Ginkel MS, Arends S, et al. Validation of the ACR-EULAR criteria for primary Sjögren's syndrome in a Dutch prospective diagnostic cohort. Rheumatology. 2018;57(5):818–825.
   PubMed Web of Science ®Google Scholar
• Shen L, Zhang C, Wang T, et al. Development of autoimmunity in IL-14alpha-transgenic mice. J Immunol. 2006;177(8):5676–5686.
   PubMed Web of Science ®Google Scholar
• Pani B, Xibao L, Bollimuntha S, et al. Impairment of TRPC1-STIM1 channel assembly and AQP5 translocation compromise agonist-stimulated fluid secretion in mice lacking caveolin1. J Cell Sci. 2013;126(Pt 2):667–675.
   PubMed Web of Science ®Google Scholar
• Resing KA, Meyer-Arendt K, Mendoza AM, Aveline-Wolf LD, et al. Improving reproducibility and sensitivity in identifying human proteins by shotgun proteomics. Anal Chem. 2004;76(13):3556–3568.
   PubMed Web of Science ®Google Scholar
• Liu X, Singh BB, Ambudkar IS. ATP-dependent activation of KCa and ROMK-type KATP channels in human submandibular gland ductal cells. J Biol Chem. 1999;274(35):25121–25129.
   PubMed Web of Science ®Google Scholar
• Singh BB, Zheng C, Liu X, et al. Trp1-dependent enhancement of salivary gland fluid secretion: role of store-operated calcium entry. FASEB J. 2001;15(9):1652–1654.
   PubMedGoogle Scholar
• Baylin SB, Ohm JE. Ohm Epigenetic gene silencing in cancer - a mechanism for early oncogenic pathway addiction? Nat Rev Cancer. 2006;6(2):107–116.
   PubMed Web of Science ®Google Scholar
• Ehlers MR. Immune-modulating effects of alpha-1 antitrypsin. Biol Chem. 2014;395(10):1187–1193.
   PubMed Web of Science ®Google Scholar
• Huber-Lang M, Ekdahl KN, Wiegner R, et al. Auxiliary activation of the complement system and its importance for the pathophysiology of clinical conditions. Semin Immunopathol. 2018;40(1):87–102.
   PubMed Web of Science ®Google Scholar
• Arvaniti P, Le Dantec C, Charras A, et al. Linking genetic variation with epigenetic profiles in Sjögren's syndrome. Clin Immunol. 2020;210:108314.
   PubMed Web of Science ®Google Scholar
• Imgenberg-Kreuz J, Almlöf JC, Leonard D, et al. Shared and unique patterns of DNA methylation in systemic lupus erythematosus and primary Sjögren’s syndrome. Front Immunol. 2019;10:1686.
   PubMed Web of Science ®Google Scholar
• Aslani S, Mahmoudi M, Karami J, et al. Epigenetic alterations underlying autoimmune diseases. Autoimmunity. 2016;49(2):69–83.
   PubMed Web of Science ®Google Scholar
• Nayar G, Gauna A, Chukkapalli S, et al. Polymicrobial infection alter inflammatory microRNA in rat salivary glands during periodontal disease. Anaerobe. 2016;38:70–75.
   PubMed Web of Science ®Google Scholar
• Hassan T, Carroll TP, Buckley PG, et al. miR-199a-5p silencing regulates the unfolded protein response in chronic obstructive pulmonary disease and α1-antitrypsin deficiency. Am J Respir Crit Care Med. 2014;189(3):263–273.
   PubMed Web of Science ®Google Scholar